Treatment of superficial dyspareunia using topical estrogens in postmenopausal women with a history of endometriosis

Treatment of superficial dyspareunia using topical estrogens in postmenopausal women with a history of endometriosis By Hale Goksever Celik

Genitourinary syndrome of menopause is defined as a collection of symptoms and signs caused by hypoestrogenic changes to the labia majora/minora, clitoris, vestibule/introitus, vagina, urethra, and bladder that occur in menopausal patients. Sexual dysfunction and superficial dyspareunia can be experienced…

Key Points Lay Summary

Endometriosis disease modelling via induced pluripotent stem cells has been successful

Endometriosis disease modelling via induced pluripotent stem cells has been successful By Nasuhi Engin Aydin

J. Julie Kim, S. Y. Hung Research Professor and Professor of ObGyn, Reproductive Science in Medicine, Northwestern University, Chicago, Illinois, has delivered a conference at the  Annual International Medical Conference of the Endometriosis Foundation of America held in New York on April 1-2,…

Key Points Lay Summary

Scientific unfolding will lead new drug targets

Scientific unfolding will lead new drug targets By Nasuhi Engin Aydin

Drs. Dolmans and Donnez from academic institutions located in Brussels, Belgium, have published their comprehensive review on the current pathophysiological concepts in endometriosis with possible drug treatment potentials in the recent issue of a scientific journal named “Biomolecules”.  As a…

Key Points Lay Summary

What causes pelvic pain? Androgens or estrogens?

What causes pelvic pain? Androgens or estrogens? By Selma Oransay

A comparison between women and men reveals that women suffer more pelvic pain. This reality raises the possibility of the pain-relieving effect of testosterone or androgens. It would be a wise solution to investigate how androgens affect pain at different…

Key Points Lay Summary

Phytoestrogens could have promising effects in endometriosis management

Phytoestrogens could have promising effects in endometriosis management By Nasuhi Engin Aydin

Dr. Bartiromo and associates from Milan, Italy published a systematic review on phytoestrogens and endometriosis in the periodical “Nutrients”. Endometriosis has features of chronic inflammation based on uncontrolled hormonal response and immune-mediated dysfunctions. Estrogens are endocrine and paracrine agents that could yield…

Key Points Lay Summary

Resveratrol, isoflavones and puerarin have favorable in vivo results in endometriosis studies

Resveratrol, isoflavones and puerarin have favorable in vivo results in endometriosis studies By Nasuhi Engin Aydin

Xia Cai and associates from research units located in China published their review article on the relationship between phytoestrogens and endometriosis in the scientific periodical named “Pharmacology”. The great variation in the prevalence of endometriosis raises questions in regard to…

Key Points Lay Summary

The role of hormonal treatment after endometriosis surgery

The role of hormonal treatment after endometriosis surgery By Bahar Yuksel

Postoperative hormonal suppression after endometriosis surgery still does not have a uniform approach. The meta-analysis study conducted by Zakhari et al. aimed to find a significant answer regarding this burden. They analyzed the database systems including MEDLINE, Embase, Cochrane CENTRAL,…

Key Points Lay Summary

A new target for the treatment of endometriosis?

A new target for the treatment of endometriosis? By Dr. Youngran Park

Endometriosis affects around 10% of women in reproductive age, estimating more than 176 million women worldwide. Inflammation in the pelvic cavity is very common in endometriosis patients. Therefore, there are high concentrations of cytokines and immune cells in the peritoneal…

Key Points Lay Summary

What happens to women with endometriosis after menopause?

What happens to women with endometriosis after menopause? By Selma Oransay

Endometriosis affects women in their reproductive period of life, with expected regression of lesions in the postmenopausal period. Literature about postmenopausal endometriosis assessing the prevalence, pathogenesis, and treatment is limited. As 2-5 % of postmenopausal women are affected by this uncommon condition, developing stress…

Key Points Lay Summary

Factors Affecting Women’s Choices to Enter Clinical Trials

Factors Affecting Women’s Choices to Enter Clinical Trials By Özge Özkaya

Women were strongly influenced by their previous experiences and personal circumstances when deciding to take part in a clinical trial. This is based on the findings of a study published in the journal Pilot and Feasibility Studies that explored the…

Key Points Lay Summary

A clearer picture of "endometriosis after menopause"

A clearer picture of By Irem Onur

Delfin Avendano Tan and Marie Josephine Guanlao Almeria are obstetrician-gynecologists from the Philippines. They recently published a review article titled "Postmenopausal endometriosis: drawing a clearer picture". In this paper, the authors discussed the pathogenesis, risk factors, and management of postmenopausal…

Key Points Lay Summary